PAR PHARM FDA Approval ANDA 089126

ANDA 089126

PAR PHARM

FDA Drug Application

Application #089126

Application Sponsors

ANDA 089126PAR PHARM

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL325MG;200MG0MEPROBAMATE AND ASPIRINASPIRIN; MEPROBAMATE

CDER Filings

PAR PHARM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 89126
            [companyName] => PAR PHARM
            [docInserts] => ["",""]
            [products] => [{"drugName":"MEPROBAMATE AND ASPIRIN","activeIngredients":"ASPIRIN; MEPROBAMATE","strength":"325MG;200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"MEPROBAMATE AND ASPIRIN","submission":"ASPIRIN; MEPROBAMATE","actionType":"325MG;200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.